| 1 |
Prospective nanoparticle treatments for lymphangioleiomyomatosis |
|
| | Emelie Landh, Roger Wang, Lyn M. Moir, Daniela Traini, Paul M. Young, Hui Xin Ong | | | Expert Opinion on Drug Delivery. 2022; : 1 | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
Liposomal drug delivery to manage nontuberculous mycobacterial pulmonary disease and other chronic lung infections |
|
| | James D. Chalmers,Jakko van Ingen,Roald van der Laan,Jean-Louis Herrmann | | | European Respiratory Review. 2021; 30(161): 210010 | | | [Pubmed] [Google Scholar] [DOI] | | | 3 |
A Phospholipid-Based Formulation for the Treatment of Airway Inflammation in Chronic Respiratory Diseases |
|
| | Varsha Komalla,Venkata Sita Rama Raju Allam,Philip Chi Lip Kwok,Behjat Sheikholeslami,Louisa Owen,Adam Jaffe,Shafagh A Waters,Shiva Mohammad,Brian Gregory Oliver,Hui Chen,Mehra Haghi | | | European Journal of Pharmaceutics and Biopharmaceutics. 2020; | | | [Pubmed] [Google Scholar] [DOI] | |
|
